Florwick Alyssa, Dharmaraj Tejas, Jurgens Julie, Valle David, Wilson Katherine L
Department of Cell Biology, Johns Hopkins University School of Medicine, BaltimoreMD, United States.
McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, BaltimoreMD, United States.
Front Genet. 2017 Jun 15;8:79. doi: 10.3389/fgene.2017.00079. eCollection 2017.
Mutations in , encoding nuclear intermediate filament proteins lamins A and C, cause multiple diseases ('laminopathies') including muscular dystrophy, dilated cardiomyopathy, familial partial lipodystrophy (FPLD2), insulin resistance syndrome and progeria. To assess the prevalence of missense mutations ('variants') in a broad, ethnically diverse population, we compared missense alleles found among 60,706 unrelated individuals in the ExAC cohort to those identified in 1,404 individuals in the laminopathy database (UMD-LMNA). We identified 169 variants in the ExAC cohort, of which 37 (∼22%) are disease-associated including p.I299V (allele frequency 0.0402%), p.G602S (allele frequency 0.0262%) and p.R644C (allele frequency 0.124%), suggesting certain mutations are more common than previously recognized. Independent analysis of variants via the type 2 diabetes (T2D) Knowledge Portal showed that variant p.G602S associated significantly with type 2 diabetes ( = 0.02; odds ratio = 4.58), and was more frequent in African Americans (allele frequency 0.297%). The FPLD2-associated variant I299V was most prevalent in Latinos (allele frequency 0.347%). The ExAC cohort also revealed 132 novel missense variants including p.K108E (limited to individuals with psychiatric disease; predicted to perturb coil-1B), p.R397C and p.R427C (predicted to perturb filament biogenesis), p.G638R and p.N660D (predicted to perturb prelamin A processing), and numerous Ig-fold variants predicted to perturb phenotypically characteristic protein-protein interactions. Overall, this two-pronged strategy- mining a large database for missense variants in a single gene (), coupled to knowledge about the structure, biogenesis and functions of A-type lamins- revealed an unexpected number of variants, including novel variants predicted to perturb lamin assembly or function. Interestingly, this study also correlated novel variant p.K108E with psychiatric disease, identified known variant p.I299V as a potential risk factor for metabolic disease in Latinos, linked variant p.G602 with type 2 diabetes, and identified p.G602S as a predictor of diabetes risk in African Americans.
编码核中间丝蛋白核纤层蛋白A和C的基因发生突变,会引发多种疾病(“核纤层蛋白病”),包括肌肉萎缩症、扩张型心肌病、家族性部分脂肪营养不良(FPLD2)、胰岛素抵抗综合征和早衰症。为了评估在一个广泛的、种族多样的人群中错义突变(“变体”)的发生率,我们将ExAC队列中60706名无关个体中发现的错义等位基因与核纤层蛋白病数据库(UMD-LMNA)中1404名个体中鉴定出的等位基因进行了比较。我们在ExAC队列中鉴定出169个变体,其中37个(约22%)与疾病相关,包括p.I299V(等位基因频率0.0402%)、p.G602S(等位基因频率0.0262%)和p.R644C(等位基因频率0.124%),这表明某些基因的突变比之前认为的更为常见。通过2型糖尿病(T2D)知识门户对这些变体进行的独立分析表明,变体p.G602S与2型糖尿病显著相关(P = 0.02;优势比 = 4.58),并且在非裔美国人中更为常见(等位基因频率0.297%)。与FPLD2相关的变体I299V在拉丁裔中最为普遍(等位基因频率0.347%)。ExAC队列还揭示了132个新的基因错义变体,包括p.K108E(仅限于患有精神疾病的个体;预计会干扰卷曲螺旋1B)、p.R397C和p.R427C(预计会干扰细丝生物合成)、p.G638R和p.N660D(预计会干扰前体核纤层蛋白A的加工),以及许多预计会干扰表型特征性蛋白质-蛋白质相互作用的免疫球蛋白折叠变体。总体而言,这种双管齐下的策略——在一个单一基因()的错义变体中挖掘一个大型数据库,并结合关于A型核纤层蛋白的结构、生物合成和功能的知识——揭示了数量意外的变体,包括预计会干扰核纤层蛋白组装或功能的新变体。有趣的是,这项研究还将新变体p.K108E与精神疾病相关联,将已知变体p.I299V确定为拉丁裔代谢疾病的潜在风险因素,将变体p.G602与2型糖尿病联系起来,并将p.G602S确定为非裔美国人糖尿病风险的预测指标。